Royal Bank Of Canada Arca Biopharma, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$1.71 - $4.0 $39 - $92
-23 Reduced 41.07%
33 $0
Q1 2024

Nov 05, 2024
BUY
$1.58 - $1.78 $36 - $40
23 Added 69.7%
56 $0
Q4 2023

Feb 14, 2024
SELL
$1.7 - $2.05 $11 - $14
-7 Reduced 11.11%
56 $0
Q3 2023

Nov 14, 2023
SELL
$2.01 - $2.07 $391 - $403
-195 Reduced 75.58%
63 $0
Q2 2023

Aug 14, 2023
BUY
$1.94 - $2.11 $500 - $544
258 New
258 $0

Others Institutions Holding ABIO

# of Institutions
2
Shares Held
280K
Call Options Held
0
Put Options Held
0
View Full List

About ARCA biopharma, Inc.

ABIO Quotes by TradingView
  • Ticker ABIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,410,100
  • Description
  • ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...
More about ABIO
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email